FindTrial
Sign In

Retrospective study on risk factors related for recurrence of ameloblastoma

Retrospective study on risk factors related for recurrence of ameloblastoma

Status
Unknown
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000041196
Enrollment
Unknown
Registered
2020-12-21
Start date
2021-01-01
Completion date
Unknown
Last updated
2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ameloblastoma

Interventions

case series :Nil

Sponsors

The First Affiliated Hospital, College of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The routine pathology report from March 2009 to March 2019 was ameloblastoma, and the outpatient follow-up was more than 1 year.

Exclusion criteria

Exclusion criteria: Patients who had been pathologically diagnosed as ameloblastoma before March 2009, and only relapsed between March 2009 and March 2019.

Design outcomes

Primary

MeasureTime frame
Recurrence or not;Surgical procedure;Tumor site;—

Countries

China

Contacts

Public ContactLing Bi

The First Affiliated Hospital, College of Medicine, Zhejiang University

lingbi@zju.edu.cn+86 13758211996

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026